The smart Trick of Hormone Replacement Therapy Alternative Treatment That Nobody is Talking About

The smart Trick of Hormone Replacement Therapy Alternative Treatment That Nobody is Talking About


Not known Factual Statements About Hormone Replacement Therapy - Rowlett, TX & Garland, TX

Accessed March 25, 2020. Martin KA, et al. Menopausal hormonal agent therapy: Advantages and risks. https://www. uptodate.com/contents/search. Accessed March 25, 2020. American College of Obstetricians and Gynecologists. Practice Publication No. 141: Management of menopausal symptoms. Obstetrics & Gynecology. 2014; doi:10. 1097/01. AOG.0000441353. 20693.78. Reaffirmed 2018. North American Menopause Society. The 2017 hormone therapy position statement of The North American Menopause Society.

2017; doi:10. 1097/GME.0000000000000921. North American Menopause Society. Nonhormonal management of menopause-associated vasomotor signs: 2015 position statement of The North American Menopause Society. Menopause. 2015; doi:10. 1097/GME.0000000000000546.

Rossouw JE, Anderson GL, Prentice RL, et al. Risks and advantages of estrogen plus progestin in healthy postmenopausal women: primary outcomes from the Women's Health Effort randomized controlled trial. JAMA 2002; 288( 3 ):321333. Anderson GL, Limacher M, Assaf AR, et al. Effects of conjugated equine estrogen in postmenopausal ladies with hysterectomy: The Women's Health Effort randomized controlled trial.

Hormone Replacement Therapy Now Available to Optimize Recovery After Surgery

Does hormone replacement therapy (HRT) increase cancer risk? - Cancer Research UK

An Unbiased View of Menopausal Hormone Therapy and Cancer Risk

Heiss G, Wallace R, Anderson GL, et al. Health risks and benefits 3 years after stopping randomized treatment with estrogen and progestin. JAMA 2008; 299( 9 ):10361045. La, Croix AZ, Chlebowski RT, Manson JE, et al. Health outcomes after stopping conjugated horse estrogens amongst postmenopausal women with prior hysterectomy: a randomized regulated trial.

Anderson GL, Judd HL, Kaunitz AM, et al. Impacts of estrogen plus progestin on gynecologic cancers and associated diagnostic treatments: The Women's Health Effort randomized trial. JAMA 2003; 290( 13 ):1739 -1748. Hendrix SL, Cochrane BB, Nygaard IE, et al. Impacts of estrogen with and without progestin on urinary incontinence. Related Source Here ( 8 ):935 -948.

Report Page